Your shopping cart is currently empty

α-Glucosidase-IN-55 (Compound 8g) is an orally active, competitive inhibitor of α-glucosidase with an IC50 value of 12.1 µM and a Ki value of 9.66 µM. It is useful for research related to Type 2 Diabetes Mellitus (T2DM), as it can enhance glycemic control and metabolic health.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | α-Glucosidase-IN-55 (Compound 8g) is an orally active, competitive inhibitor of α-glucosidase with an IC50 value of 12.1 µM and a Ki value of 9.66 µM. It is useful for research related to Type 2 Diabetes Mellitus (T2DM), as it can enhance glycemic control and metabolic health. |
| In vivo | α-Glucosidase-IN-55, administered orally at doses of 2-8 mg/kg once daily for 28 days, significantly reduces fasting blood glucose (FBG) levels in diabetic rats. |
| Formula | C31H22ClN3S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.